Stanozolin Depot-50 Lyka Labs

£57.00

Stanozolin Depot-50 Lyka Labs provides researchers with 50mg/ml stanozolol suspension for investigating anabolic steroid mechanisms and receptor binding studies in controlled laboratory environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Stanozolin Depot-50 Lyka Labs
Stanozolin Depot-50 Lyka Labs
£57.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview: Stanozolin Depot-50 Lyka Labs

Stanozolin Depot-50 is a pharmaceutical-grade stanozolol suspension formulated by Lyka Labs for in-vitro research applications. This anabolic steroid preparation offers researchers a standardised 50mg/ml concentration for investigating androgen receptor binding mechanisms and protein synthesis pathways. The depot formulation provides sustained release characteristics ideal for extended laboratory studies examining steroid pharmacokinetics and metabolic processes.

Research facilities studying anabolic compounds often require reliable preparations from established manufacturers. This product joins our comprehensive range available at Stroid UK Shop, where researchers can access various pharmaceutical compounds for comparative studies. The stanozolol suspension format allows for precise volumetric measurements in experimental protocols.

Laboratory Research Applications

Researchers utilise Stanozolin Depot-50 to investigate stanozolol’s molecular interactions with androgen receptors and examine its influence on cellular protein synthesis mechanisms. The compound serves as a reference standard for studying DHT-derived anabolic steroids and their metabolic pathways. Laboratory studies frequently examine stanozolol’s structural modifications compared to testosterone and analyse its reduced androgenic properties relative to anabolic effects.

Comparative research often involves analysing this preparation alongside other anabolic compounds from our stanozolol category. Scientists investigating performance-enhancing substances examine stanozolol’s tissue-selective properties and metabolic fate. Research protocols may also compare stanozolol preparations with compounds from our SARMs and peptides collections to evaluate different mechanisms of action.

Technical Specifications

Stanozolin Depot-50 Research Specifications
Parameter Specification
Active Compound Stanozolol
Concentration 50mg/ml
Formulation Injectable suspension
Manufacturer Lyka Labs
Volume 10ml vial
CAS Number 10418-03-8
Molecular Formula C21H32N2O
Storage Room temperature, protected from light

Research Compliance Statement

Stanozolin Depot-50 Lyka Labs is manufactured exclusively for in-vitro laboratory research and analytical applications. This product is not intended for human consumption, therapeutic use, or any purpose outside controlled laboratory environments. Researchers must maintain appropriate safety protocols and regulatory compliance when handling this research compound.

Related